Pharmaceutical

Huadong enters licence deal for MC2 Therapeutics’ Wynzora cream

Huadong has entered into an agreement to acquire licence rights for MC2 Therapeutics’ Wynzora cream in Greater China.

Sep 1, 2023 - 20:00
Huadong enters licence deal for MC2 Therapeutics’ Wynzora cream
Huadong has entered into an agreement to acquire licence rights for MC2 Therapeutics’ Wynzora cream in Greater China.
Read the original article

Tags:

Previous Article

Reset Pharma partners with Filament to license psilocybin drug

Next Article

Otsuka Pharmaceutical agrees to buy Mindset Pharma

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Former Surgeon General Jerome Adams: Prioritize new antivirals for Covid

Opinion: Former Surgeon General Jerome Adams: Prioritiz...

Jun 22, 2023

STAT+: Ozempic 3.0? Lilly’s ‘triple-G’ drug shows biggest weight loss yet in mid-stage trial

STAT+: Ozempic 3.0? Lilly’s ‘triple-G’ drug shows bigge...

Jun 26, 2023

FDA approves Moderna’s RSV vaccine mRESVIA

FDA approves Moderna’s RSV vaccine mRESVIA

Jun 4, 2024